<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-04-27" modified="2020-10-07" version="192">
<accession>P58012</accession>
<accession>Q4ZGJ3</accession>
<name>FOXL2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Forkhead box protein L2</fullName>
</recommendedName>
</protein>
<gene>
<name type="primary">FOXL2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Nat. Genet." volume="27" first="159" last="166">
<title>The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome.</title>
<authorList>
<person name="Crisponi L."/>
<person name="Deiana M."/>
<person name="Loi A."/>
<person name="Chiappe F."/>
<person name="Uda M."/>
<person name="Amati P."/>
<person name="Bisceglia L."/>
<person name="Zelante L."/>
<person name="Nagaraja R."/>
<person name="Porcu S."/>
<person name="Ristaldi M.S."/>
<person name="Marzella R."/>
<person name="Rocchi M."/>
<person name="Nicolino M."/>
<person name="Lienhardt-Roussie A."/>
<person name="Nivelon A."/>
<person name="Verloes A."/>
<person name="Schlessinger D."/>
<person name="Gasparini P."/>
<person name="Bonneau D."/>
<person name="Cao A."/>
<person name="Pilia G."/>
</authorList>
<dbReference type="PubMed" id="11175783"/>
<dbReference type="DOI" id="10.1038/84781"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT BPES ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-234 INS</scope>
</reference>
<reference key="2">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<title>Study of mutations of FOXL2 gene in a Chinese TongHai family with blepharophimosis-ptosis-epicanthus inversus syndrome.</title>
<authorList>
<person name="Xu Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT BPES ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-234 INS</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="336" first="876" last="881">
<title>Transcriptional factor FOXL2 interacts with DP103 and induces apoptosis.</title>
<authorList>
<person name="Lee K."/>
<person name="Pisarska M.D."/>
<person name="Ko J.J."/>
<person name="Kang Y."/>
<person name="Yoon S."/>
<person name="Ryou S.M."/>
<person name="Cha K.Y."/>
<person name="Bae J."/>
</authorList>
<dbReference type="PubMed" id="16153597"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.08.184"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>INTERACTION WITH DDX20</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2009" name="Cell. Signal." volume="21" first="1935" last="1944">
<title>Sumoylation of forkhead L2 by Ubc9 is required for its activity as a transcriptional repressor of the steroidogenic acute regulatory gene.</title>
<authorList>
<person name="Kuo F.T."/>
<person name="Bentsi-Barnes I.K."/>
<person name="Barlow G.M."/>
<person name="Bae J."/>
<person name="Pisarska M.D."/>
</authorList>
<dbReference type="PubMed" id="19744555"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2009.09.001"/>
</citation>
<scope>FUNCTION AS TRANSCRIPTIONAL REPRESSOR OF STAR</scope>
<scope>INTERACTION WITH UBE2I</scope>
<scope>SUMOYLATION AT LYS-25</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-25</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2009" name="Hum. Mol. Genet." volume="18" first="632" last="644">
<title>Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations.</title>
<authorList>
<person name="Benayoun B.A."/>
<person name="Batista F."/>
<person name="Auer J."/>
<person name="Dipietromaria A."/>
<person name="L'Hote D."/>
<person name="De Baere E."/>
<person name="Veitia R.A."/>
</authorList>
<dbReference type="PubMed" id="19010791"/>
<dbReference type="DOI" id="10.1093/hmg/ddn389"/>
</citation>
<scope>FUNCTION AS TRANSCRIPTIONAL ACTIVATOR OF SIRT1</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2009" name="J. Med. Genet." volume="46" first="455" last="457">
<title>Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2.</title>
<authorList>
<person name="Laissue P."/>
<person name="Lakhal B."/>
<person name="Benayoun B.A."/>
<person name="Dipietromaria A."/>
<person name="Braham R."/>
<person name="Elghezal H."/>
<person name="Philibert P."/>
<person name="Saad A."/>
<person name="Sultan C."/>
<person name="Fellous M."/>
<person name="Veitia R.A."/>
</authorList>
<dbReference type="PubMed" id="19429596"/>
<dbReference type="DOI" id="10.1136/jmg.2008.065086"/>
</citation>
<scope>FUNCTION AS TRANSCRIPTIONAL ACTIVATOR OF OSR2</scope>
<scope>VARIANT POF3 ASP-187</scope>
<scope>CHARACTERIZATION OF VARIANT POF3 ASP-187</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="24" first="189" last="193">
<title>The human FOXL2 mutation database.</title>
<authorList>
<person name="Beysen D."/>
<person name="Vandesompele J."/>
<person name="Messiaen L."/>
<person name="De Paepe A."/>
<person name="De Baere E."/>
</authorList>
<dbReference type="PubMed" id="15300845"/>
<dbReference type="DOI" id="10.1002/humu.20079"/>
</citation>
<scope>DATABASE OF FOXL2 VARIANTS</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="1591" last="1600">
<title>Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype -- phenotype correlation.</title>
<authorList>
<person name="De Baere E."/>
<person name="Dixon M.J."/>
<person name="Small K.W."/>
<person name="Jabs E.W."/>
<person name="Leroy B.P."/>
<person name="Devriendt K."/>
<person name="Gillerot Y."/>
<person name="Mortier G."/>
<person name="Meire F."/>
<person name="Van Maldergem L."/>
<person name="Courtens W."/>
<person name="Hjalgrim H."/>
<person name="Huang S."/>
<person name="Liebaers I."/>
<person name="Van Regemorter N."/>
<person name="Touraine P."/>
<person name="Praphanphoj V."/>
<person name="Verloes A."/>
<person name="Udar N."/>
<person name="Yellore V."/>
<person name="Chalukya M."/>
<person name="Yelchits S."/>
<person name="De Paepe A."/>
<person name="Kuttenn F."/>
<person name="Fellous M."/>
<person name="Veitia R."/>
<person name="Messiaen L."/>
</authorList>
<dbReference type="PubMed" id="11468277"/>
<dbReference type="DOI" id="10.1093/hmg/10.15.1591"/>
</citation>
<scope>VARIANTS BPES ILE-85 DEL AND PHE-217</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Am. J. Med. Genet." volume="113" first="47" last="51">
<title>Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families.</title>
<authorList>
<person name="Ramirez-Castro J.L."/>
<person name="Pineda-Trujillo N."/>
<person name="Valencia A.V."/>
<person name="Muneton C.M."/>
<person name="Botero O."/>
<person name="Trujillo O."/>
<person name="Vasquez G."/>
<person name="Mora B.E."/>
<person name="Durango N."/>
<person name="Bedoya G."/>
<person name="Ruiz-Linares A."/>
</authorList>
<dbReference type="PubMed" id="12400065"/>
<dbReference type="DOI" id="10.1002/ajmg.10741"/>
</citation>
<scope>VARIANT BPES ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-234 INS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Med. Genet." volume="39" first="E43" last="E43">
<title>FOXL2 mutation screening in a large panel of POF patients and XX males.</title>
<authorList>
<person name="De Baere E."/>
<person name="Lemercier B."/>
<person name="Christin-Maitre S."/>
<person name="Durval D."/>
<person name="Messiaen L."/>
<person name="Fellous M."/>
<person name="Veitia R."/>
</authorList>
<dbReference type="PubMed" id="12161610"/>
<dbReference type="DOI" id="10.1136/jmg.39.8.e43"/>
</citation>
<scope>VARIANTS ASP-187 AND SER-285</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Mol. Hum. Reprod." volume="8" first="729" last="733">
<title>Identification of novel mutations in FOXL2 associated with premature ovarian failure.</title>
<authorList>
<person name="Harris S.E."/>
<person name="Chand A.L."/>
<person name="Winship I.M."/>
<person name="Gersak K."/>
<person name="Aittomaeki K."/>
<person name="Shelling A.N."/>
</authorList>
<dbReference type="PubMed" id="12149404"/>
<dbReference type="DOI" id="10.1093/molehr/8.8.729"/>
</citation>
<scope>VARIANTS POF3 221-ALA--ALA-230 DEL AND ASN-258</scope>
<scope>VARIANT GLY-179</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Am. J. Hum. Genet." volume="72" first="478" last="487">
<title>FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation.</title>
<authorList>
<person name="De Baere E."/>
<person name="Beysen D."/>
<person name="Oley C."/>
<person name="Lorenz B."/>
<person name="Cocquet J."/>
<person name="De Sutter P."/>
<person name="Devriendt K."/>
<person name="Dixon M.J."/>
<person name="Fellous M."/>
<person name="Fryns J.-P."/>
<person name="Garza A."/>
<person name="Jonsrud C."/>
<person name="Koivisto P.A."/>
<person name="Krause A."/>
<person name="Leroy B.P."/>
<person name="Meire F."/>
<person name="Plomp A."/>
<person name="Van Maldergem L."/>
<person name="De Paepe A."/>
<person name="Veitia R."/>
<person name="Messiaen L."/>
</authorList>
<dbReference type="PubMed" id="12529855"/>
<dbReference type="DOI" id="10.1086/346118"/>
</citation>
<scope>VARIANTS BPES PHE-106; LYS-109 AND PHE-217</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Clin. Genet." volume="63" first="117" last="120">
<title>Sporadic and familial blepharophimosis -ptosis-epicanthus inversus syndrome: FOXL2 mutation screen and MRI study of the superior levator eyelid muscle.</title>
<authorList>
<person name="Dollfus H."/>
<person name="Stoetzel C."/>
<person name="Riehm S."/>
<person name="Lahlou Boukoffa W."/>
<person name="Bediard Boulaneb F."/>
<person name="Quillet R."/>
<person name="Abu-Eid M."/>
<person name="Speeg-Schatz C."/>
<person name="Francfort J.J."/>
<person name="Flament J."/>
<person name="Veillon F."/>
<person name="Perrin-Schmitt F."/>
</authorList>
<dbReference type="PubMed" id="12630957"/>
<dbReference type="DOI" id="10.1034/j.1399-0004.2003.00011.x"/>
</citation>
<scope>VARIANT BPES SER-84</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="22" first="222" last="228">
<title>Comparative analysis of the FOXL2 gene and characterization of mutations in BPES patients.</title>
<authorList>
<person name="Udar N."/>
<person name="Yellore V."/>
<person name="Chalukya M."/>
<person name="Yelchits S."/>
<person name="Silva-Garcia R."/>
<person name="Small K."/>
</authorList>
<dbReference type="PubMed" id="12938087"/>
<dbReference type="DOI" id="10.1002/humu.10251"/>
</citation>
<scope>VARIANT BPES ARG-104</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Mol. Vis." volume="10" first="445" last="449">
<title>Genetic analysis of a five generation Indian family with BPES: a novel missense mutation (p.Y215C).</title>
<authorList>
<person name="Kumar A."/>
<person name="Babu M."/>
<person name="Raghunath A."/>
<person name="Venkatesh C.P."/>
</authorList>
<dbReference type="PubMed" id="15257268"/>
</citation>
<scope>VARIANT BPES CYS-215</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Chin. Med. J." volume="119" first="49" last="52">
<title>Three novel FOXL2 gene mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.</title>
<authorList>
<person name="Or S.F."/>
<person name="Tong M.F."/>
<person name="Lo F.M."/>
<person name="Lam T.S."/>
</authorList>
<dbReference type="PubMed" id="16454982"/>
</citation>
<scope>VARIANT BPES THR-63</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Hum. Genet." volume="121" first="107" last="112">
<title>A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction.</title>
<authorList>
<person name="Nallathambi J."/>
<person name="Moumne L."/>
<person name="De Baere E."/>
<person name="Beysen D."/>
<person name="Usha K."/>
<person name="Sundaresan P."/>
<person name="Veitia R.A."/>
</authorList>
<dbReference type="PubMed" id="17089161"/>
<dbReference type="DOI" id="10.1007/s00439-006-0276-0"/>
</citation>
<scope>VARIANT BPES ALA-ALA-ALA-ALA-ALA-234 INS</scope>
<scope>CHARACTERIZATION OF VARIANT BPES ALA-ALA-ALA-ALA-ALA-234 INS</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Hum. Mol. Genet." volume="17" first="2030" last="2038">
<title>Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation.</title>
<authorList>
<person name="Beysen D."/>
<person name="Moumne L."/>
<person name="Veitia R."/>
<person name="Peters H."/>
<person name="Leroy B.P."/>
<person name="De Paepe A."/>
<person name="De Baere E."/>
</authorList>
<dbReference type="PubMed" id="18372316"/>
<dbReference type="DOI" id="10.1093/hmg/ddn100"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS BPES LEU-58; VAL-66; LYS-69; THR-80; ASN-84; SER-90; GLY-98; ARG-101; THR-102; CYS-103; ARG-104; PHE-106; PRO-106; LYS-109 AND PHE-217</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Hum. Mutat." volume="29" first="E123" last="E131">
<title>Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients.</title>
<authorList>
<person name="Nallathambi J."/>
<person name="Laissue P."/>
<person name="Batista F."/>
<person name="Benayoun B.A."/>
<person name="Lesaffre C."/>
<person name="Moumne L."/>
<person name="Pandaranayaka P.E."/>
<person name="Usha K."/>
<person name="Krishnaswamy S."/>
<person name="Sundaresan P."/>
<person name="Veitia R.A."/>
</authorList>
<dbReference type="PubMed" id="18484667"/>
<dbReference type="DOI" id="10.1002/humu.20809"/>
</citation>
<scope>VARIANTS BPES ARG-98; PRO-108; CYS-215; CYS-217 AND ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-234 INS</scope>
<scope>VARIANT GLY-179</scope>
<scope>CHARACTERIZATION OF VARIANTS BPES PRO-108 AND CYS-217</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Hum. Mutat." volume="29" first="E205" last="E219">
<title>Identification of 34 novel and 56 known FOXL2 mutations in patients with blepharophimosis syndrome.</title>
<authorList>
<person name="Beysen D."/>
<person name="De Jaegere S."/>
<person name="Amor D."/>
<person name="Bouchard P."/>
<person name="Christin-Maitre S."/>
<person name="Fellous M."/>
<person name="Touraine P."/>
<person name="Grix A.W."/>
<person name="Hennekam R."/>
<person name="Meire F."/>
<person name="Oyen N."/>
<person name="Wilson L.C."/>
<person name="Barel D."/>
<person name="Clayton-Smith J."/>
<person name="de Ravel T."/>
<person name="Decock C."/>
<person name="Delbeke P."/>
<person name="Ensenauer R."/>
<person name="Ebinger F."/>
<person name="Gillessen-Kaesbach G."/>
<person name="Hendriks Y."/>
<person name="Kimonis V."/>
<person name="Laframboise R."/>
<person name="Laissue P."/>
<person name="Leppig K."/>
<person name="Leroy B.P."/>
<person name="Miller D.T."/>
<person name="Mowat D."/>
<person name="Neumann L."/>
<person name="Plomp A."/>
<person name="Van Regemorter N."/>
<person name="Wieczorek D."/>
<person name="Veitia R.A."/>
<person name="De Paepe A."/>
<person name="De Baere E."/>
</authorList>
<dbReference type="PubMed" id="18642388"/>
<dbReference type="DOI" id="10.1002/humu.20819"/>
</citation>
<scope>VARIANTS BPES LEU-58; VAL-65; VAL-66; LYS-69; THR-80; ASN-84; SER-90; GLY-98; ARG-101; THR-102; CYS-103 AND PRO-106</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="N. Engl. J. Med." volume="360" first="2719" last="2729">
<title>Mutation of FOXL2 in granulosa-cell tumors of the ovary.</title>
<authorList>
<person name="Shah S.P."/>
<person name="Kobel M."/>
<person name="Senz J."/>
<person name="Morin R.D."/>
<person name="Clarke B.A."/>
<person name="Wiegand K.C."/>
<person name="Leung G."/>
<person name="Zayed A."/>
<person name="Mehl E."/>
<person name="Kalloger S.E."/>
<person name="Sun M."/>
<person name="Giuliany R."/>
<person name="Yorida E."/>
<person name="Jones S."/>
<person name="Varhol R."/>
<person name="Swenerton K.D."/>
<person name="Miller D."/>
<person name="Clement P.B."/>
<person name="Crane C."/>
<person name="Madore J."/>
<person name="Provencher D."/>
<person name="Leung P."/>
<person name="DeFazio A."/>
<person name="Khattra J."/>
<person name="Turashvili G."/>
<person name="Zhao Y."/>
<person name="Zeng T."/>
<person name="Glover J.N."/>
<person name="Vanderhyden B."/>
<person name="Zhao C."/>
<person name="Parkinson C.A."/>
<person name="Jimenez-Linan M."/>
<person name="Bowtell D.D."/>
<person name="Mes-Masson A.M."/>
<person name="Brenton J.D."/>
<person name="Aparicio S.A."/>
<person name="Boyd N."/>
<person name="Hirst M."/>
<person name="Gilks C.B."/>
<person name="Marra M."/>
<person name="Huntsman D.G."/>
</authorList>
<dbReference type="PubMed" id="19516027"/>
<dbReference type="DOI" id="10.1056/nejmoa0902542"/>
</citation>
<scope>VARIANT TRP-134</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E7988" last="E7988">
<title>The specificity of the FOXL2 c.402C&gt;G Somatic mutation: a survey of solid tumors.</title>
<authorList>
<person name="Schrader K.A."/>
<person name="Gorbatcheva B."/>
<person name="Senz J."/>
<person name="Heravi-Moussavi A."/>
<person name="Melnyk N."/>
<person name="Salamanca C."/>
<person name="Maines-Bandiera S."/>
<person name="Cooke S.L."/>
<person name="Leung P."/>
<person name="Brenton J.D."/>
<person name="Gilks C.B."/>
<person name="Monahan J."/>
<person name="Huntsman D.G."/>
</authorList>
<dbReference type="PubMed" id="19956657"/>
<dbReference type="DOI" id="10.1371/journal.pone.0007988"/>
</citation>
<scope>VARIANT TRP-134</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="39" last="42">
<title>Identical NR5A1 missense mutations in two unrelated 46,XX individuals with testicular tissues.</title>
<authorList>
<person name="Igarashi M."/>
<person name="Takasawa K."/>
<person name="Hakoda A."/>
<person name="Kanno J."/>
<person name="Takada S."/>
<person name="Miyado M."/>
<person name="Baba T."/>
<person name="Morohashi K.I."/>
<person name="Tajima T."/>
<person name="Hata K."/>
<person name="Nakabayashi K."/>
<person name="Matsubara Y."/>
<person name="Sekido R."/>
<person name="Ogata T."/>
<person name="Kashimada K."/>
<person name="Fukami M."/>
</authorList>
<dbReference type="PubMed" id="27610946"/>
<dbReference type="DOI" id="10.1002/humu.23116"/>
</citation>
<scope>VARIANT GLY-349</scope>
</reference>
<comment type="function">
<text evidence="2 13 19 20 22">Transcriptional regulator. Critical factor essential for ovary differentiation and maintenance, and repression of the genetic program for somatic testis determination. Prevents trans-differentiation of ovary to testis through transcriptional repression of the Sertoli cell-promoting gene SOX9 (By similarity). Has apoptotic activity in ovarian cells. Suppresses ESR1-mediated transcription of PTGS2/COX2 stimulated by tamoxifen (By similarity). Is a regulator of CYP19 expression (By similarity). Participates in SMAD3-dependent transcription of FST via the intronic SMAD-binding element (By similarity). Is a transcriptional repressor of STAR. Activates SIRT1 transcription under cellular stress conditions. Activates transcription of OSR2.</text>
</comment>
<comment type="subunit">
<text evidence="2 13 22">Interacts with ESR1 (By similarity). Interacts with SMAD3 (By similarity). Interacts with DDX20. Interacts with UBE2I/UBC9.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3 22">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>In addition to its expression in the developing eyelid, it is transcribed very early in somatic cells of the developing gonad (before sex determination) and its expression persists in the follicular cells of the adult ovary.</text>
</comment>
<comment type="induction">
<text evidence="19">In granulosa-like cells, up-regulated at transcript and protein levels under oxidative stress and heat-shock conditions. Down-regulated by SIRT1.</text>
</comment>
<comment type="PTM">
<text evidence="22">Sumoylated with SUMO1; sumoylation is required for transcriptional repression activity.</text>
</comment>
<comment type="disease" evidence="4 5 8 9 10 11 12 14 15 16 17 18 25">
<disease id="DI-01287">
<name>Blepharophimosis, ptosis, and epicanthus inversus syndrome</name>
<acronym>BPES</acronym>
<description>A disorder characterized by eyelid dysplasia, small palpebral fissures, drooping eyelids and a skin fold curving in the mediolateral direction, inferior to the inner canthus. In type I BPSE (BPES1) eyelid abnormalities are associated with female infertility. Affected females show an ovarian deficit due to primary amenorrhea or to premature ovarian failure (POF). In type II BPSE (BPES2) affected individuals show only the eyelid defects.</description>
<dbReference type="MIM" id="110100"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry. There is a mutational hotspot in the region coding for the poly-Ala domain, since 30% of all mutations in the ORF lead to poly-Ala expansions, resulting mainly in BPES type II.</text>
</comment>
<comment type="disease" evidence="6 20">
<disease id="DI-02193">
<name>Premature ovarian failure 3</name>
<acronym>POF3</acronym>
<description>An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol.</description>
<dbReference type="MIM" id="608996"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Forkhead box L2 (FOXL2)">
<link uri="https://lovd.cmgg.be/index.php?select_db=FOXL2"/>
<text>Leiden Open Variation Database (LOVD)</text>
</comment>
<dbReference type="EMBL" id="AF301906">
<property type="protein sequence ID" value="AAK01352.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ016609">
<property type="protein sequence ID" value="AAY21823.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC062549">
<property type="protein sequence ID" value="AAH62549.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3105.1"/>
<dbReference type="RefSeq" id="NP_075555.1">
<property type="nucleotide sequence ID" value="NM_023067.3"/>
</dbReference>
<dbReference type="SMR" id="P58012"/>
<dbReference type="BioGRID" id="107136">
<property type="interactions" value="67"/>
</dbReference>
<dbReference type="IntAct" id="P58012">
<property type="interactions" value="53"/>
</dbReference>
<dbReference type="MINT" id="P58012"/>
<dbReference type="STRING" id="9606.ENSP00000333188"/>
<dbReference type="iPTMnet" id="P58012"/>
<dbReference type="PhosphoSitePlus" id="P58012"/>
<dbReference type="BioMuta" id="FOXL2"/>
<dbReference type="DMDM" id="13626838"/>
<dbReference type="jPOST" id="P58012"/>
<dbReference type="MassIVE" id="P58012"/>
<dbReference type="PaxDb" id="P58012"/>
<dbReference type="PeptideAtlas" id="P58012"/>
<dbReference type="PRIDE" id="P58012"/>
<dbReference type="ProteomicsDB" id="57047"/>
<dbReference type="Antibodypedia" id="17961">
<property type="antibodies" value="355 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000648323">
<property type="protein sequence ID" value="ENSP00000497217"/>
<property type="gene ID" value="ENSG00000183770"/>
</dbReference>
<dbReference type="GeneID" id="668"/>
<dbReference type="KEGG" id="hsa:668"/>
<dbReference type="CTD" id="668"/>
<dbReference type="DisGeNET" id="668"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000183770.5"/>
<dbReference type="GeneCards" id="FOXL2"/>
<dbReference type="GeneReviews" id="FOXL2"/>
<dbReference type="HGNC" id="HGNC:1092">
<property type="gene designation" value="FOXL2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000183770">
<property type="expression patterns" value="Tissue enhanced (cervix, uterine, ovary, parathyroid gland)"/>
</dbReference>
<dbReference type="MalaCards" id="FOXL2"/>
<dbReference type="MIM" id="110100">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="605597">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="608996">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P58012"/>
<dbReference type="OpenTargets" id="ENSG00000183770"/>
<dbReference type="Orphanet" id="572333">
<property type="disease" value="Blepharophimosis-ptosis-epicanthus inversus syndrome plus"/>
</dbReference>
<dbReference type="Orphanet" id="572354">
<property type="disease" value="Blepharophimosis-ptosis-epicanthus inversus syndrome type 1"/>
</dbReference>
<dbReference type="Orphanet" id="572361">
<property type="disease" value="Blepharophimosis-ptosis-epicanthus inversus syndrome type 2"/>
</dbReference>
<dbReference type="Orphanet" id="99915">
<property type="disease" value="Maligant granulosa cell tumor of the ovary"/>
</dbReference>
<dbReference type="Orphanet" id="619">
<property type="disease" value="NON RARE IN EUROPE: Primary ovarian failure"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28235"/>
<dbReference type="eggNOG" id="KOG2294">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000162075"/>
<dbReference type="HOGENOM" id="CLU_023357_1_0_1"/>
<dbReference type="InParanoid" id="P58012"/>
<dbReference type="KO" id="K09405"/>
<dbReference type="OMA" id="HCSYWEH"/>
<dbReference type="OrthoDB" id="1270467at2759"/>
<dbReference type="PhylomeDB" id="P58012"/>
<dbReference type="TreeFam" id="TF316127"/>
<dbReference type="PathwayCommons" id="P58012"/>
<dbReference type="Reactome" id="R-HSA-3232118">
<property type="pathway name" value="SUMOylation of transcription factors"/>
</dbReference>
<dbReference type="SIGNOR" id="P58012"/>
<dbReference type="BioGRID-ORCS" id="668">
<property type="hits" value="104 hits in 891 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="Forkhead_box_L2"/>
<dbReference type="GenomeRNAi" id="668"/>
<dbReference type="Pharos" id="P58012">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P58012"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="P58012">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000183770">
<property type="expression patterns" value="Expressed in female gonad and 59 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P58012">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P58012">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0045171">
<property type="term" value="C:intercellular bridge"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043028">
<property type="term" value="F:cysteine-type endopeptidase regulator activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0030331">
<property type="term" value="F:estrogen receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031624">
<property type="term" value="F:ubiquitin conjugating enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009653">
<property type="term" value="P:anatomical structure morphogenesis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006309">
<property type="term" value="P:apoptotic DNA fragmentation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048048">
<property type="term" value="P:embryonic eye morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002074">
<property type="term" value="P:extraocular skeletal muscle development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019101">
<property type="term" value="P:female somatic sex determination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060014">
<property type="term" value="P:granulosa cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001555">
<property type="term" value="P:oocyte growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001541">
<property type="term" value="P:ovarian follicle development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043280">
<property type="term" value="P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046881">
<property type="term" value="P:positive regulation of follicle-stimulating hormone secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033686">
<property type="term" value="P:positive regulation of luteinizing hormone secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007338">
<property type="term" value="P:single fertilization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060065">
<property type="term" value="P:uterus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00059">
<property type="entry name" value="FH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001766">
<property type="entry name" value="Fork_head_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR018122">
<property type="entry name" value="TF_fork_head_CS_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR030456">
<property type="entry name" value="TF_fork_head_CS_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00250">
<property type="entry name" value="Forkhead"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00053">
<property type="entry name" value="FORKHEAD"/>
</dbReference>
<dbReference type="SMART" id="SM00339">
<property type="entry name" value="FH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00657">
<property type="entry name" value="FORK_HEAD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00658">
<property type="entry name" value="FORK_HEAD_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50039">
<property type="entry name" value="FORK_HEAD_3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1066">Premature ovarian failure</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0818">Triplet repeat expansion</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Forkhead box protein L2" id="PRO_0000091861">
<location>
<begin position="1"/>
<end position="376"/>
</location>
</feature>
<feature type="DNA-binding region" description="Fork-head" evidence="3">
<location>
<begin position="54"/>
<end position="148"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="35"/>
<end position="43"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="221"/>
<end position="234"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="284"/>
<end position="292"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="301"/>
<end position="304"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="33"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)">
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; sporadic; nuclear and cytoplasmic aggregation; impaired transactivation activity." id="VAR_021196" evidence="16 18">
<original>S</original>
<variation>L</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; dbSNP:rs1315073489." id="VAR_062545" evidence="14">
<original>I</original>
<variation>T</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; dbSNP:rs1559922621." id="VAR_046490" evidence="18">
<original>M</original>
<variation>V</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; nuclear and cytoplasmic aggregation; impaired transactivation activity." id="VAR_021197" evidence="16 18">
<original>A</original>
<variation>V</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; sporadic; nuclear aggregation; normal transactivation activity; dbSNP:rs387906920." id="VAR_021198" evidence="16 18">
<original>E</original>
<variation>K</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; nuclear and cytoplasmic aggregation; impaired transactivation activity." id="VAR_046491" evidence="16 18">
<original>I</original>
<variation>T</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; nuclear and cytoplasmic aggregation; impaired transactivation activity." id="VAR_046492" evidence="16 18">
<original>I</original>
<variation>N</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; type I; dbSNP:rs28937884." id="VAR_016883" evidence="10">
<original>I</original>
<variation>S</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; sporadic." id="VAR_016884" evidence="5">
<location>
<position position="85"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; nuclear and cytoplasmic aggregation; impaired transactivation activity." id="VAR_046493" evidence="16 18">
<original>F</original>
<variation>S</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; nuclear and cytoplasmic aggregation; impaired transactivation activity." id="VAR_046494" evidence="16 18">
<original>W</original>
<variation>G</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; dbSNP:rs1057516149." id="VAR_062546" evidence="17">
<original>W</original>
<variation>R</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; nuclear aggregation; impaired transactivation activity; dbSNP:rs1057516151." id="VAR_046495" evidence="16 18">
<original>S</original>
<variation>R</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; nuclear and cytoplasmic aggregation; impaired transactivation activity." id="VAR_046496" evidence="16 18">
<original>I</original>
<variation>T</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; nuclear and cytoplasmic aggregation; normal transactivation activity." id="VAR_046497" evidence="16 18">
<original>R</original>
<variation>C</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; diffuse nuclear localization as wild type; normal transactivation activity; dbSNP:rs1057516153." id="VAR_021199" evidence="11 16">
<original>H</original>
<variation>R</variation>
<location>
<position position="104"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; type II." id="VAR_021200">
<original>N</original>
<variation>S</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; sporadic; nuclear and cytoplasmic aggregation; impaired transactivation activity; dbSNP:rs1057516156." id="VAR_016885" evidence="9 16">
<original>L</original>
<variation>F</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; nuclear and cytoplasmic aggregation; impaired transactivation activity." id="VAR_046498" evidence="16 18">
<original>L</original>
<variation>P</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; nuclear aggregation and cytoplasmic mislocalization; impaired transactivation activity." id="VAR_062547" evidence="17">
<original>L</original>
<variation>P</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; type II; diffuse nuclear localization as wild type; impaired transactivation activity." id="VAR_016886" evidence="9 16">
<original>N</original>
<variation>K</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="sequence variant" description="In granulosa-cell tumors of the ovary; not commonly found in other tumor types; dbSNP:rs1057519865." id="VAR_062548" evidence="21 23">
<original>C</original>
<variation>W</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7432551." id="VAR_021201" evidence="6 17">
<original>A</original>
<variation>G</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In POF3; does not affect nuclear localization; reduces transcriptional activation of OSR2; dbSNP:rs121908359." id="VAR_015181" evidence="7 20">
<original>G</original>
<variation>D</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; type II; dbSNP:rs1057516162." id="VAR_021202">
<original>K</original>
<variation>R</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; dbSNP:rs1057516168." id="VAR_021203" evidence="12 17">
<original>Y</original>
<variation>C</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; diffuse nuclear localization; normal transcriptional activation." id="VAR_062549" evidence="17">
<original>S</original>
<variation>C</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; diffuse nuclear localization; increased transactivation activity; dbSNP:rs797044527." id="VAR_016887" evidence="5 9 16">
<original>S</original>
<variation>F</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; significant higher cytoplasmic retention compared to the wild-type protein." id="VAR_037303" evidence="15">
<original>A</original>
<variation>AAAAAA</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES; type II." id="VAR_010782" evidence="4 8">
<original>A</original>
<variation>AAAAAAAAAAA</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In BPES." id="VAR_025306" evidence="25">
<original>A</original>
<variation>AAAAAAAAAAAA</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In POF3; dbSNP:rs28937885." id="VAR_021204" evidence="6">
<original>Y</original>
<variation>N</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_015182" evidence="7">
<original>P</original>
<variation>S</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs201840174." id="VAR_078138" evidence="24">
<original>R</original>
<variation>G</variation>
<location>
<position position="349"/>
</location>
</feature>
<feature type="mutagenesis site" description="Results in reduced sumoylation. Loss of transcriptional repression activity." evidence="22">
<original>K</original>
<variation>R</variation>
<location>
<position position="25"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00089"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11175783"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11468277"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12149404"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12161610"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12400065"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12529855"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12630957"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12938087"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15257268"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16153597"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16454982"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17089161"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18372316"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18484667"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18642388"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19010791"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19429596"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19516027"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19744555"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19956657"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27610946"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="2"/>
</evidence>
<sequence length="376" mass="38772" checksum="B4952F2A0380E533" modified="2001-04-27" version="1">MMASYPEPEDAAGALLAPETGRTVKEPEGPPPSPGKGGGGGGGTAPEKPDPAQKPPYSYVALIAMAIRESAEKRLTLSGIYQYIIAKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRPPPAHFQPGKGLFGAGGAAGGCGVAGAGADGYGYLAPPKYLQSGFLNNSWPLPQPPSPMPYASCQMAAAAAAAAAAAAAAGPGSPGAAAVVKGLAGPAASYGPYTRVQSMALPPGVVNSYNGLGGPPAAPPPPPHPHPHPHAHHLHAAAAPPPAPPHHGAAAPPPGQLSPASPATAAPPAPAPTSAPGLQFACARQPELAMMHCSYWDHDSKTGALHSRLDL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

